INS and type 1 diabetes mellitus: In experiments with mice with type 1 diabetes, the nanosystem rapidly released insulin and maintained normal blood sugar levels for up to 84 h with a single injection, without affecting the blood sugar levels of healthy mice (Fig. 3) [122].